Found: 199
Select item for more details and to access through your institution.
Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100 mg, 200/150 mg and 200/50 mg twice daily in HIV-negative volunteers.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Use of specific antimicrobials for COVID-19: should we prescribe them now or wait for more evidence?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals.
- Published in:
- 2006
- By:
- Publication type:
- commentary
Estimated generic prices for novel treatments for drug-resistant tuberculosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Global patient safety and antiretroviral drug–drug interactions in the resource-limited setting.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 1, p. 1, doi. 10.1093/jac/dks346
- By:
- Publication type:
- Article
Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 9, p. 2213, doi. 10.1093/jac/dks207
- By:
- Publication type:
- Article
Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 5, p. 1217, doi. 10.1093/jac/dkr596
- By:
- Publication type:
- Article
Ageing with HIV: medication use and risk for potential drug–drug interactions.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 9, p. 2107
- By:
- Publication type:
- Article
Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 6, p. 1332, doi. 10.1093/jac/dkr087
- By:
- Publication type:
- Article
Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 1, p. 180, doi. 10.1093/jac/dkq411
- By:
- Publication type:
- Article
New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 6, p. 1079, doi. 10.1093/jac/dkq086
- By:
- Publication type:
- Article
Concentration-dependent effects and intracellular accumulation of HIV protease inhibitors in cultured CD4 T cells and primary human lymphocytes.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 5, p. 906, doi. 10.1093/jac/dkq082
- By:
- Publication type:
- Article
Co-administration of fluconazole increases nevirapine concentrations in HIV-infected Ugandans.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 2, p. 316, doi. 10.1093/jac/dkp451
- By:
- Publication type:
- Article
Factors influencing lopinavir and atazanavir plasma concentration.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 1, p. 129, doi. 10.1093/jac/dkp408
- By:
- Publication type:
- Article
Pharmacokinetics of nevirapine in HIV-infected children with and without malnutrition receiving divided adult fixed-dose combination tablets.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 6, p. 1251, doi. 10.1093/jac/dkp358
- By:
- Publication type:
- Article
Intracellular accumulation of efavirenz and nevirapine is independent of P-glycoprotein activity in cultured CD4 T cells and primary human lymphocytes.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 5, p. 1002, doi. 10.1093/jac/dkp335
- By:
- Publication type:
- Article
Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 1, p. 5, doi. 10.1093/jac/dkp152
- By:
- Publication type:
- Article
Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 6, p. 1233, doi. 10.1093/jac/dkp102
- By:
- Publication type:
- Article
Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 6, p. 1344, doi. 10.1093/jac/dkn399
- By:
- Publication type:
- Article
Pharmacokinetic analysis to assess forgiveness of boosted saquinavir regimens for missed or late dosing.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 1, p. 161, doi. 10.1093/jac/dkn187
- By:
- Publication type:
- Article
Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 61, n. 4, p. 914
- By:
- Publication type:
- Article
Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2007, v. 60, n. 5, p. 987, doi. 10.1093/jac/dkm353
- By:
- Publication type:
- Article
Factors impacting the expression of membrane-bound proteins in lymphocytes from HIV-positive subjects.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2007, v. 60, n. 3, p. 685, doi. 10.1093/jac/dkm230
- By:
- Publication type:
- Article
Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 58, n. 6, p. 1299, doi. 10.1093/jac/dkl399
- By:
- Publication type:
- Article
Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individuals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 4, p. 738, doi. 10.1093/jac/dki308
- By:
- Publication type:
- Article
Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2004, v. 54, n. 2, p. 498, doi. 10.1093/jac/dkh357
- By:
- Publication type:
- Article
Marked variation in pyrimethamine disposition in AIDS patients treated for cerebral toxoplasmosis.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Longitudinal Pharmacokinetic-Pharmacodynamic Biomarkers Correlate With Treatment Outcome in Drug-Sensitive Pulmonary Tuberculosis: A Population Pharmacokinetic-Pharmacodynamic Analysis.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 7, p. 1, doi. 10.1093/ofid/ofaa218
- By:
- Publication type:
- Article
Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 2, p. N.PAG, doi. 10.1093/ofid/ofy032
- By:
- Publication type:
- Article
Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 3, p. 609, doi. 10.1007/s40121-024-00935-0
- By:
- Publication type:
- Article
Tenofovir Disoproxil Fumarate Fails to Prevent HIV Acquisition or the Establishment of a Viral Reservoir: Two Case Reports.
- Published in:
- Infectious Diseases & Therapy, 2016, v. 5, n. 1, p. 65, doi. 10.1007/s40121-015-0102-x
- By:
- Publication type:
- Article
Cerebrospinal fluid drug concentrations and viral suppression in HIV-1-infected patients receiving ritonavir-boosted atazanavir plus lamivudine dual antiretroviral therapy (Spanish HIV/AIDS Research Network, PreEC/RIS 39).
- Published in:
- Journal of NeuroVirology, 2018, v. 24, n. 4, p. 391, doi. 10.1007/s13365-018-0626-4
- By:
- Publication type:
- Article
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia.
- Published in:
- Journal of NeuroVirology, 2016, v. 22, n. 6, p. 852, doi. 10.1007/s13365-016-0448-1
- By:
- Publication type:
- Article
Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment.
- Published in:
- Drugs in R&D, 2021, v. 21, n. 1, p. 9, doi. 10.1007/s40268-020-00333-0
- By:
- Publication type:
- Article
Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 6, p. 1285, doi. 10.3390/pharmaceutics14061285
- By:
- Publication type:
- Article
Interactions of Tenofovir, Lamivudine, Abacavir and Didanosine in Primary Human Cells.
- Published in:
- Pharmaceutics, 2011, v. 3, n. 2, p. 326, doi. 10.3390/pharmaceutics3020326
- By:
- Publication type:
- Article
Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults.
- Published in:
- AIDS Research & Treatment, 2012, p. 1, doi. 10.1155/2012/105980
- By:
- Publication type:
- Article
Approaches to accelerating the study of new antiretrovirals in pregnancy.
- Published in:
- Journal of the International AIDS Society, 2022, v. 25, p. 1, doi. 10.1002/jia2.25916
- By:
- Publication type:
- Article
Clinical and population‐based study design considerations to accelerate the investigation of new antiretrovirals during pregnancy.
- Published in:
- Journal of the International AIDS Society, 2022, v. 25, p. 1, doi. 10.1002/jia2.25917
- By:
- Publication type:
- Article
Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?
- Published in:
- Journal of the International AIDS Society, 2019, v. 22, n. 9, p. N.PAG, doi. 10.1002/jia2.25372
- By:
- Publication type:
- Article
Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects.
- Published in:
- Journal of the International AIDS Society, 2019, v. 22, n. 7, p. N.PAG, doi. 10.1002/jia2.25352
- By:
- Publication type:
- Article
Choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?
- Published in:
- Journal of the International AIDS Society, 2016, v. 19, n. 1, p. 1, doi. 10.7448/IAS.19.1.20504
- By:
- Publication type:
- Article
Should the dose of tenofovir be reduced to 200-250 mg/day, when combined with protease inhibitors?
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19583
- By:
- Publication type:
- Article
Simulation of the impact of rifampicin on darunavir/ritonavir PK and dose adjustment strategies in HIV-infected patients: a population PK approach.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19586
- By:
- Publication type:
- Article
Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19484
- By:
- Publication type:
- Article
Darunavir pharmacokinetics throughout pregnancy and postpartum.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19485
- By:
- Publication type:
- Article
Undeclared pre-exposure or post-exposure prophylaxis (PrEP/PEP) use among syphilis-positive blood donors, England, 2020 to 2021.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 11, p. 2, doi. 10.2807/1560-7917.ES.2023.28.11.2300135
- By:
- Publication type:
- Article
Two cases of monkey pox imported to the United Kingdom, September 2018.
- Published in:
- Eurosurveillance (15607917), 2018, v. 23, n. 38, p. 2, doi. 10.2807/1560-7917.ES.2018.23.38.1800509
- By:
- Publication type:
- Article